The broad objective of the Research Education Component is to enrich and support the training of a diverse group of future research leaders in the study of Alzheimer's Disease (AD)-related disorders and brain aging. We will provide a varied range of experiences and activities so that participants gain an integrated perspective to perform critical and impactful studies of AD, related disorders, and brain aging. Use of an interdisciplinary scientific approach will be emphasized, and key features of sound and effective translational science will be highlighted. This component incorporates continuation of activities that were previously successfully implemented in the Outreach and Recruitment Core (formerly entitled the Education and Information Transfer Core). The plan includes travel awards, ethics training, encouragement of underrepresented minorities, mentoring opportunities, continuing education activities, exposure to scientific and public conferences, and information distribution by referencing the availability of the ADCC's resources and research opportunities. The Research Education Component will train, nurture, and support graduate students, postdoctoral fellows, junior faculty, and research associates by leveraging the interdisciplinary and collaborative nature of faculty in the ADCC and related programs. Opportunities will be provided for maximal career development and growth to lead to research independence.
The Specific Aims of the Research Education Component address the overarching goals to train, enrich, and provide opportunities for participants so that they develop into research leaders in the field of AD, related disorders, and brain aging.
Specific Aim 1 is to provide personalized mentorship and activities geared toward each participant's prior experience and current interests, leading to maximal career development and research independence.
Specific Aim 2 is to ensure exemplary training and exposure to the field of AD, related disorders, and brain research using a collaborative, interdisciplinary, and systems scientific approach that underscores the importance of translating basic science discoveries to impactful and real-world clinical outcomes.
Specific Aim 3 is to instruct and require adherence to the responsible conduct of research. The program faculty mentors associated with this component span numerous areas of expertise which, together, encompass an interdisciplinary, multifaceted systems approach to AD and aging. The breadth and depth of foci across laboratories allows a dynamic and systematic approach to mentoring, providing tremendous opportunities to personalize the mentee's research exposure based on their own goals and background. Moreover, the collaborative nature of our already established ADCC yields connectedness across program faculty, providing abundant opportunities for training in multiple dimensions and techniques directly applicable to understanding and intervening with AD and aging processes. Of critical importance to training researchers in the field of AD and aging, the Research Education Component builds on the many existing strengths of the ADCC to formalize training and education opportunities in a common geographical location, Arizona.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Arizona State University-Tempe Campus
United States
Zip Code
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Ortuño-Lizarán, Isabel; Esquiva, Gema; Beach, Thomas G et al. (2018) Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease. Acta Neuropathol Commun 6:90
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Chakrabarty, Paramita; Li, Andrew; Ladd, Thomas B et al. (2018) TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease. J Exp Med 215:2247-2264
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Andrews, Megan; Tousi, Babak; Sabbagh, Marwan N (2018) 5HT6 Antagonists in the Treatment of Alzheimer's Dementia: Current Progress. Neurol Ther 7:51-58
Grilli, Matthew D; Wank, Aubrey A; Bercel, John J et al. (2018) Evidence for Reduced Autobiographical Memory Episodic Specificity in Cognitively Normal Middle-Aged and Older Individuals at Increased Risk for Alzheimer's Disease Dementia. J Int Neuropsychol Soc 24:1073-1083
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826

Showing the most recent 10 out of 794 publications